Biora Therapeutics Inc (BIOR) — Financial Flexibility Index

Latest as of September 2024: -0.07x

Biora Therapeutics Inc (BIOR) has a Financial Flexibility Index of -0.07x as of September 2024. Free cash flow of $-8.71 Million (operating CF $-8.73 Million minus capex $19.00K) represents 0% of total liabilities ($121.13 Million). Also explore BIOR net asset momentum to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.07x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-8.71 Million
Operating CF − Capex

Total Liabilities

$121.13 Million
USD

Capital Expenditures

$19.00K
USD

Biora Therapeutics Inc Financial Flexibility Index (2018–2023)

Historical Financial Flexibility Index trend for Biora Therapeutics Inc across 6 annual periods. Check BIOR asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Annual Financial Flexibility Index for Biora Therapeutics Inc (2018–2023)

Year-by-year free cash flow to debt coverage for Biora Therapeutics Inc. For the full company profile including market capitalisation, see BIOR stock market capitalisation.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2023 -0.36x $-48.40 Million $-48.50 Million $132.64 Million ▲ +10.6%
2022 -0.41x $-63.62 Million $-64.42 Million $155.81 Million ▲ +52.5%
2021 -0.86x $-166.63 Million $-167.49 Million $193.81 Million ▼ -39.8%
2020 -0.62x $-160.80 Million $-165.74 Million $261.43 Million ▼ -11.5%
2019 -0.55x $-102.40 Million $-106.12 Million $185.60 Million ▼ -40.3%
2018 -0.39x $-60.29 Million $-65.13 Million $153.37 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities